Skip to main content

Free Content IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library


An increased IgM concentration in cerebrospinal fluid (CSF), occurring as a consequence of massive intrathecal IgM synthesis, is a marker of interest for diagnosis of the meningo-encephalitic stage in human African trypanosomiasis. However, in current practice, IgM in CSF is not determined because of the lack of a simple and robust test that is applicable in African rural regions where the disease prevails. We describe the development of a sensitive semiquantitative card agglutination test, LATEX/IgM, for IgM quantification in CSF. The test is simple and fast and the lyophilized reagent remains stable even at 45 °C. CSF end-titres obtained with LATEX/IgM parallel the IgM concentrations determined by nephelometry and enzyme-linked immunosorbent assay. Detection of intrathecal IgM synthesis is the most sensitive marker for CNS involvement in sleeping sickness. At a cut-off value of ≥ 8, the sensitivity and specificity of LATEX/IgM for intrathecal IgM synthesis are 89.4 and 92.7%. As a consequence, patients with LATEX/IgM end-titres ≥ 8 are likely to have intrathecal IgM synthesis, thus central nervous system involvement and therefore should be treated accordingly. Further studies should concentrate on the relationship between the LATEX/IgM end-titres, presence of intrathecal IgM synthesis and occurrence of treatment failures in patients treated with pentamidine.

Keywords: IgM; Trypanosoma brucei gambiense; card agglutination; cerebrospinal fluid; intrathecal IgM synthesis; latex microspheres; sleeping sickness; stage determination

Document Type: Research Article


Affiliations: 1: EPICENTRE, Paris, France, 2: International Medical Corps, Nairobi, Kenya, 3: Médecins Sans Frontières-Espagne, Haut Mbomou, République Centrafricaine, 4: Institut Pierre Richet, Bouaké, Côte d'Ivoire, 5: OCEAC Laboratoire d'Etude de la Chimiosensibilité des Trypanosomes, Yaoundé, Cameroun, 6: Projet de Recherches Cliniques sur la Trypanosomiase, Daloa, Côte d'Ivoire, 7: Bureau Central de la Trypanosomiase, Bwamanda, R.D. Congo, 8: Department of Parasitology, Institute of Tropical Medicine, Antwerpen, Belgium, 9: Department of Clinical Sciences, Institute of Tropical Medicine, Antwerpen, Belgium, 10: Merck Eurolab, Fontenay-sous-Bois, France

Publication date: August 1, 2002


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more